Dental Care Clinics in Mount Sinai, NY Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Mt. Sinai Family Dental Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 5505 Nesconset Hwy, Ste. 230, Mount Sinai, NY 11766 Phone: 631-331-8989 Fax: 631-331-7962 |
Kahn,kahn,kahn & Hludzinski Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 701 Route 25a, Suite 1a, Mount Sinai, NY 11766 Phone: 631-473-5715 |
James P. Denunzio, D.d.s., P.l.l.c. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 5505 Nesconset Hwy Ste 230, Mount Sinai, NY 11766 Phone: 631-331-8989 |
Dental365 Mt Sinai Dentist Medicare: Not Enrolled in Medicare Practice Location: 701 Route 25a Ste A1, Mount Sinai, NY 11766 Phone: 631-331-4067 Fax: 516-344-5748 |
News Archive
Hungry people crave more variety
You're whale watching in Alaska, longing for a margarita and a spot on a beach. You think to yourself, "How did I get here? I hate the cold. Never finished Moby Dick. And I get seasick!" A fascinating new study from the Journal of Consumer Research finds that when we long for something intensely - like a much-needed vacation - a wider array of options will sound appealing, potentially leading to some out-of-character choices.
Study examines why young people with Type-2 diabetes develop heart problems
A new study led by a research team at Leicester's Hospitals hope to reveal, using magnetic resonance imaging (MRI), why young people with Type-2 diabetes develop heart damage.
Advanced Cell Technology's MA09-hRPE cells for treatment of SMD: FDA grants orphan drug designation
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
Safety and oral immunogenicity of a VSV-derived mucosal vaccine against SARS-CoV-2
A team of researchers exploited the known tropism of vesicular stomatitis virus to develop an oral vaccine that expresses the immunogenic SARS-CoV-2 spike glycoprotein in the oral mucosa.
› Verified 5 days ago